Similar articles

• Anti-Trypanosoma cruzi agglutinins in acute human Chagas' disease.

  Schmuñis GA, Szarfman A, Coarasa L, Guilleron C, Peralta JM. Schmuñis GA, et al. Am J Trop Med Hyg. 1980 Mar;29(2):170-8. doi: 10.4269/ajtmh.1980.29.170. Am J Trop Med Hyg. 1980. PMID: 6768314 No abstract available.
• Presence of immunoglobulins on the surface of bloodstream Trypanosoma cruzi. Capping during differentiation in culture.

  Kloetzel J, Deane MP. Kloetzel J, et al. Rev Inst Med Trop Sao Paulo. 1977 Nov-Dec;19(6):397-402. Rev Inst Med Trop Sao Paulo. 1977. PMID: 418490 No abstract available.
• Membrane-bound antibodies to bloodstream Trypanosoma cruzi in mice: strain differences in susceptibility to complement-mediated lysis.

  Krettli AU, Weisz-Carrington P, Nussenzweig RS. Krettli AU, et al. Clin Exp Immunol. 1979 Sep;37(3):416-23. Clin Exp Immunol. 1979. PMID: 116784 Free PMC article.
• The unmet medical need for Trypanosoma cruzi-infected patients: Monitoring the disease status.

  Zrein M, Chatelain E. Zrein M, et al. Biochim Biophys Acta Mol Basis Dis. 2020 Mar 1;1866(3):165628. doi: 10.1016/j.bbadis.2019.165628. Epub 2019 Dec 4. Biochim Biophys Acta Mol Basis Dis. 2020. PMID: 31809789 Review.
• Mouse as a model for Chagas disease: does mouse represent a good model for Chagas disease?

  Costa SC. Costa SC. Mem Inst Oswaldo Cruz. 1999;94 Suppl 1:269-72. doi: 10.1590/s0074-02761999000700045. Mem Inst Oswaldo Cruz. 1999. PMID: 10677731 Review. No abstract available.